You have 9 free searches left this month | for more free features.

Leukemia, B-Cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-cell Leukemia Trial in Sanhe (CD19/CD20 Dual-CAR-T cells)

Completed
  • B-cell Leukemia
  • CD19/CD20 Dual-CAR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Mar 6, 2022

NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

Not yet recruiting
  • NHL, Relapsed, Adult
  • +3 more
  • KUR-502
  • (no location specified)
Aug 2, 2022

Lymphoma, B-Cell, Leukemia, B-cell, Leukemia, T-Cell Trial in Cangzhou (CAR-T)

Recruiting
  • Lymphoma, B-Cell
  • +3 more
  • CAR-T
  • Cangzhou, Hebei, China
    Cangzhou People's Hospital
Nov 9, 2022

Leukemia, B-Cell Trial in Houston (Autologous TriCAR T-cells and lymphodepletion chemo)

Not yet recruiting
  • Leukemia, B-Cell
  • Autologous TriCAR T-cells and lymphodepletion chemotherapy
  • Houston, Texas
  • +1 more
Nov 3, 2021

Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Whittier, California
    Innovative Clinical Research Institute
Aug 8, 2022

Leukemia, Lymphoma Trial in Wuhan (ET019003-T Cells)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • ET019003-T Cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Nov 11, 2021

B Cell Leukemias, B Cell Lymphomas Trial in Philadelphia (CART22 cells transduced with a lentiviral vector to express anti-CD22

Recruiting
  • B Cell Leukemias
  • B Cell Lymphomas
  • CART22 cells transduced with a lentiviral vector to express anti-CD22 scFv TCRz:41BB
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jan 19, 2022

Development of B-cell Leukemias and Lymphomas in Children of

Not yet recruiting
  • B Cell Leukemia
  • Lymphoma
  • SNP analysis of the DNA
  • (no location specified)
Oct 26, 2021

Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Leukemia, Lymphoma, Large B-Cell, Diffuse, Leukemia, B-cell Trial in Kunming (CD19 CAR-T cells)

Recruiting
  • Leukemia
  • +4 more
  • CD19 CAR-T cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force
Mar 1, 2021

Leukemia, Lymphoma, Leukemia, B-Cell Trial in Chongqing (CD19 CAR-T cells)

Recruiting
  • Leukemia
  • +3 more
  • CD19 CAR-T cells
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Mar 1, 2021

Leukemia, B-cell, Lymphoma, B-Cell Trial in Chongqing (CD19 and CD22 targeted CAR-T cells)

Recruiting
  • Leukemia, B-cell
  • Lymphoma, B-Cell
  • CD19 and CD22 targeted CAR-T cells
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Mar 1, 2021

B-cell Lymphoma, B-cell Leukemia Trial in Kunming (anti-CD19 UCAR-NK cells)

Recruiting
  • B-cell Lymphoma
  • B-cell Leukemia
  • anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    Kunming Hope of Health Hospital
Oct 4, 2022

B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)

Active, not recruiting
  • B Cell Leukemia
  • Autologous CD19 CAR+ EGFTt + T cells
  • Seattle, Washington
    Seattle Children's Hospital
Feb 15, 2022

B-Cell Leukemia, B-Cell Lymphoma Trial in Guangzhou (4SCAR19/22 T cells, Interleukin-2)

Suspended
  • B-Cell Leukemia
  • B-Cell Lymphoma
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Aug 9, 2021

Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

Not yet recruiting
  • Leukemia, Acute Myeloid
  • +7 more
  • Denver, Colorado
  • +3 more
May 16, 2022

Leukemia, Myeloid, Acute, Leukemia, B-cell, Leukemia, T Cell Trial in Monza (Sport Therapy)

Recruiting
  • Leukemia, Myeloid, Acute
  • +7 more
  • Sport Therapy
  • Monza, MB, Italy
    Maria Letizia Verga Center, Pediatric Clinic, University of Mila
Sep 28, 2021

Leukemia, B-cell Trial in Suzhou (?dT Cell infusion agent)

Recruiting
  • Leukemia, B-cell
  • γδT Cell infusion agent
  • Suzhou, Jiangsu, China
    No.188 Shizi Street
Jan 4, 2021

B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

Recruiting
  • B-Cell Lymphoma
  • +8 more
  • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
  • Pittsburgh, Pennsylvania
    AHN Cancer Institute - West Penn Hospital
Aug 10, 2022

B Cell Leukemia, B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Guangzhou (CAR-ITNK cells)

Recruiting
  • B Cell Leukemia
  • +4 more
  • CAR-ITNK cells
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Feb 6, 2021

Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

Recruiting
  • Lymphoma
  • +2 more
  • Kappa CD28 T cells
  • Houston, Texas
  • +1 more
Jan 31, 2022

Leukemia, B-cell, Lymphoma, B-Cell Trial in Cincinnati (Blinatumomab, Pembrolizumab)

Withdrawn
  • Leukemia, B-cell
  • Lymphoma, B-Cell
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 30, 2021

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Acute Lymphocytic Leukemia, B-Cell Trial in Taiyuan (CD19-CD22 CAR-T cells)

    Recruiting
    • Acute Lymphocytic Leukemia, B-Cell
    • CD19-CD22 CAR-T cells
    • Taiyuan, Shanxi, China
      Hematology Department of ShanXi Cancer Hospital
    Jan 17, 2021

    NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

    Completed
    • NHL
    • +17 more
    • veltuzumab
    • Savannah, Georgia
    • +4 more
    Aug 12, 2021